Effective prevention of sorafenib-related vascular damage induced adverse events and maintenance of hepatic function by dried bonito broth and histidine

Background: Sorafenib (SOR) is an anti-angiogenic chemotherapeutic that prolongs the survival rates of patients with hepatocellular carcinoma. However, SOR also damages normal vasculature and causes associated adverse events, including hand–foot syndrome and hypertension (HT). We previously reported...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Manag Res
Hlavní autoři: Sakai, Norihiro, Kamimura, Kenya, Shinagawa-Kobayashi, Yoko, Nagoya, Takuro, Niwa, Yusuke, Ko, Masayoshi, Setsu, Toru, Sakamaki, Akira, Yokoo, Takeshi, Abe, Satoshi, Kamimura, Hiroteru, Sugitani, Soichi, Yanagi, Masahiko, Terai, Shuji
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6525960/
https://ncbi.nlm.nih.gov/pubmed/31191006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S201424
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky